首页> 外文期刊>American Journal of Epidemiology >Informative Patterns of Health-Care Utilization Prior to the Diagnosis of Pancreatic Ductal Adenocarcinoma
【24h】

Informative Patterns of Health-Care Utilization Prior to the Diagnosis of Pancreatic Ductal Adenocarcinoma

机译:在诊断胰腺导管腺癌之前的医疗利用信息的信息模式

获取原文
获取原文并翻译 | 示例
           

摘要

Early-detection tests for pancreatic ductal adenocarcinoma (PDAC) are needed. Since a hypothetical screening test would be applied during antecedent clinical encounters, we sought to define the variability in health-care utilization leading up to PDAC diagnosis. This was a retrospective cohort study that included patients diagnosed with PDAC in the Indianapolis, Indiana, area between 1999 and 2013 with at least 1 health-care encounter during the antecedent 36-month period (n = 1,023). Patients were classified by unique patterns of health-care utilization using a group-based trajectory model. The prevalences of PDAC signals, such as diabetes mellitus (DM) and chronic pancreatitis, were compared. Four distinct trajectories were identified, the most common (42.0%) being having few clinical encounters more than 6 months prior to PDAC diagnosis (late acceleration). In all cases, a minority of persons had DM (30.6%, with 9.5% <1.5 years before PDAC) or any pancreatic disorder (39.9%); these were least common in the late-acceleration group (DM, 14.7%; any pancreatic disorder, 32.1% (P < 0.001)). The most common pattern of antecedent care was having few clinical encounters until shortly before PDAC diagnosis. Since the majority of patients diagnosed with PDAC do not have an antecedent PDAC signal, early-detection strategies limited to these groups may not apply to the majority of cases.
机译:需要用于胰腺导管腺癌(PDAC)的早期检测试验。由于在先令临床遭遇期间将应用假设的筛查测试,我们试图定义导致PDAC诊断的保健利用率的可变性。这是一种回顾性队列研究,包括在印第安纳州印第安纳州印第安纳州印第安纳州的PDAC患者,1999年至2013年间的区域,在前期36个月期间至少有1个医疗保健遭遇(n = 1,023)。使用基于基于组的轨迹模型,通过独特的保健利用模式进行分类。比较了PDAC信号的普遍性,例如糖尿病(DM)和慢性胰腺炎。鉴定了四种不同的轨迹,最常见的(42.0%)在PDAC诊断(晚期加速)之前超过6个月的临床遭遇超过6个月。在所有情况下,少数人都有DM(30.6%,PDAC前9.5%<5年)或任何胰腺疾病(39.9%);这些在晚加速组(DM,14.7%;任何胰腺疾病中,32.1%(P <0.001))中最不常见。疾病诊断前几乎没有临床遭遇,患有临床障碍的最常见的模式。由于诊断患有PDAC的大多数患者没有先前的PDAC信号,因此限于这些群体的早期检测策略可能不适用于大多数情况。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号